Menu
GeneBe

COX10

cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10, the group of Mitochondrial respiratory chain complex assembly factors

Basic information

Region (hg38): 17:14069489-14231736

Links

ENSG00000006695NCBI:1352OMIM:602125HGNC:2260Uniprot:Q12887AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Leigh syndrome (Definitive), mode of inheritance: AR
  • mitochondrial complex 4 deficiency, nuclear type 3 (Strong), mode of inheritance: AR
  • cytochrome-c oxidase deficiency disease (Supportive), mode of inheritance: AR
  • mitochondrial disease (Definitive), mode of inheritance: AR
  • Leigh syndrome (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitochondrial complex IV deficiency, nuclear type 3ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAudiologic/Otolaryngologic; Biochemical; Cardiovascular; Hematologic; Musculoskeletal; Neurologic10767350

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the COX10 gene.

  • not provided (177 variants)
  • Cytochrome-c oxidase deficiency disease (89 variants)
  • Leigh syndrome (89 variants)
  • Mitochondrial complex 4 deficiency, nuclear type 3 (34 variants)
  • not specified (25 variants)
  • Inborn genetic diseases (21 variants)
  • Leigh syndrome;Cytochrome-c oxidase deficiency disease (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the COX10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
33
clinvar
3
clinvar
38
missense
4
clinvar
66
clinvar
3
clinvar
2
clinvar
75
nonsense
2
clinvar
2
start loss
0
frameshift
2
clinvar
2
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
8
1
10
non coding
29
clinvar
27
clinvar
36
clinvar
92
Total 0 8 100 63 41

Highest pathogenic variant AF is 0.0000263

Variants in COX10

This is a list of pathogenic ClinVar variants found in the COX10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-14069494-G-A Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 Benign (Jun 23, 2018)321803
17-14069497-G-A Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome Benign/Likely benign (Jun 14, 2018)321804
17-14069516-G-T Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome Uncertain significance (Jan 13, 2018)321805
17-14069517-G-C Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 • Mitochondrial complex 4 deficiency, nuclear type 3 Uncertain significance (Mar 05, 2022)891985
17-14069517-G-T Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 • Mitochondrial complex 4 deficiency, nuclear type 3 Uncertain significance (Apr 20, 2022)889563
17-14069543-C-T Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 Benign/Likely benign (Jan 12, 2018)321806
17-14069566-G-A Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 Uncertain significance (Jan 13, 2018)321807
17-14069571-A-G not specified Likely benign (Nov 23, 2016)391036
17-14069577-C-A Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 Uncertain significance (Jan 13, 2018)321808
17-14069582-G-A Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 Conflicting classifications of pathogenicity (May 30, 2018)321809
17-14069607-T-C Mitochondrial complex 4 deficiency, nuclear type 3 Pathogenic (Oct 01, 2004)7527
17-14069620-G-T not specified Likely benign (Mar 22, 2016)384201
17-14069623-C-T Likely benign (Apr 22, 2022)2081819
17-14069625-C-G Inborn genetic diseases Uncertain significance (Dec 21, 2023)3076428
17-14069638-C-T not specified • Mitochondrial complex IV deficiency, nuclear type 1 • Leigh syndrome Benign/Likely benign (Jan 30, 2024)137005
17-14069639-C-T Mitochondrial complex 4 deficiency, nuclear type 3 Uncertain significance (Apr 19, 2022)1693693
17-14069658-C-G Likely benign (Sep 23, 2022)1622696
17-14069660-G-A Likely benign (Nov 22, 2022)1528991
17-14069814-T-C Benign (Jun 14, 2018)669477
17-14069832-G-T Likely benign (Jul 15, 2018)1202237
17-14074036-G-A Benign (Jul 31, 2018)1272959
17-14074145-G-A Benign (Jun 14, 2018)683588
17-14074261-G-A Likely benign (Jun 23, 2018)1198282
17-14074320-T-C Leigh syndrome • Mitochondrial complex IV deficiency, nuclear type 1 Uncertain significance (Jan 12, 2018)890219
17-14074321-A-G Uncertain significance (Nov 27, 2021)2007152

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
COX10protein_codingprotein_codingENST00000261643 7139182
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.08400.9141257360121257480.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1802662581.030.00001562814
Missense in Polyphen100116.20.860621207
Synonymous-1.021241101.120.00000707944
Loss of Function2.73517.20.2908.04e-7203

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.00005300.0000527
Middle Eastern0.000.00
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts protoheme IX and farnesyl diphosphate to heme O. {ECO:0000250}.;
Disease
DISEASE: Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations, ranging from isolated myopathy to severe multisystem disease affecting several tissues and organs. Features include hypertrophic cardiomyopathy, hepatomegaly and liver dysfunction, hypotonia, muscle weakness, exercise intolerance, developmental delay, delayed motor development and mental retardation. Some affected individuals manifest a fatal hypertrophic cardiomyopathy resulting in neonatal death. A subset of patients manifest Leigh syndrome. {ECO:0000269|PubMed:10767350, ECO:0000269|PubMed:12928484, ECO:0000269|PubMed:26741492}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Hereditary Coproporphyria (HCP);Porphyria Variegata (PV);Congenital Erythropoietic Porphyria (CEP) or Gunther Disease;Acute Intermittent Porphyria;Porphyrin Metabolism;Heme biosynthesis;Metabolism of porphyrins;Metabolism (Consensus)

Recessive Scores

pRec
0.195

Intolerance Scores

loftool
0.109
rvis_EVS
0.76
rvis_percentile_EVS
86.75

Haploinsufficiency Scores

pHI
0.0347
hipred
Y
hipred_score
0.683
ghis
0.442

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.909

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Cox10
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
mitochondrial fission;mitochondrial electron transport, cytochrome c to oxygen;heme biosynthetic process;heme a biosynthetic process;respiratory chain complex IV assembly;cellular respiration;heme O biosynthetic process;proton transmembrane transport
Cellular component
nucleolus;mitochondrion;mitochondrial inner membrane;cytosol;integral component of membrane;cytochrome complex
Molecular function
cytochrome-c oxidase activity;farnesyltranstransferase activity;protoheme IX farnesyltransferase activity